AMTB(AMTB)
AMTB
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $403M | $429M |
| Low | $402M | $423M |
| High | $404M | $435M |
| EBITDA Avg | $71M | $75M |
| Low | $70M | $74M |
| High | $71M | $76M |
| EBIT Avg | $65M | $69M |
| Low | $65M | $68M |
| High | $65M | $70M |
| Net Income Avg | $86M | $106M |
| Low | $85M | $101M |
| High | $87M | $114M |
| EPS Avg | $2.09 | $2.62 |
| Low | $2.06 | $2.45 |
| High | $2.11 | $2.78 |
| Analysts (Rev / EPS) | 3 / 3 | 3 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $102M | $104M | $104M | $106M | $109M | $111M |
| Low | $102M | $103M | $103M | $106M | $108M | $110M |
| High | $102M | $105M | $104M | $107M | $109M | $111M |
| EBITDA Avg | $18M | $18M | $18M | $19M | $19M | $19M |
| Low | $18M | $18M | $18M | $18M | $19M | $19M |
| High | $18M | $18M | $18M | $19M | $19M | $19M |
| EBIT Avg | $16M | $17M | $17M | $17M | $17M | $18M |
| Low | $16M | $17M | $17M | $17M | $17M | $18M |
| High | $16M | $17M | $17M | $17M | $18M | $18M |
| Net Income Avg | $22M | $24M | $24M | $25M | $26M | $28M |
| Low | $21M | $23M | $24M | $25M | $26M | $28M |
| High | $22M | $25M | $24M | $25M | $26M | $28M |
| EPS Avg | $0.55 | $0.61 | $0.61 | $0.63 | $0.66 | $0.70 |
| Low | $0.54 | $0.59 | $0.60 | $0.62 | $0.66 | $0.70 |
| High | $0.55 | $0.63 | $0.61 | $0.63 | $0.67 | $0.71 |
| Analysts (Rev / EPS) | 3 / 3 | 3 / 3 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |